ACE and type 2 diabetes mellitus: Support for the role of the KKS as a therapeutic target in T2D and associated complications can be inferred from the clinical experience with angiotensin converting enzyme (ACE) inhibitors which improve insulin sensitivity and glucose control in T2D patients [28].